Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02842528
Other study ID # PHRC-IR2006
Secondary ID
Status Terminated
Phase N/A
First received June 27, 2016
Last updated July 20, 2016
Start date September 2007
Est. completion date July 2009

Study information

Verified date July 2016
Source CHU de Reims
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

The purpose of this study is to specify the cognitive and genetic pattern associated with alcohol dependence. Results will help identifying more precisely vulnerability factors associated with this disorder.


Description:

Alcohol dependence involves both environmental and genetic vulnerability factors. Although it has a rather high degree of heritability (estimates range between 40% and 60%), vulnerability to alcohol dependence is broadly recognised as a complex polygenic phenotype. To clarify the risk factors involved in alcohol dependence, attempts have been made to identify endophenotypes in alcohol dependent patients and their relatives. Endophenotypes are defined as heritable traits associated with an increased risk for developing a disorder; they must be found in probands and their unaffected relatives at a higher rate than in the general population and must be associated with a specific genetic pattern. In the present study the investigators investigate the cognitive performance of alcohol dependent patients in comparison with a group of adult non-alcoholic offspring of alcohol-dependent patients and a group of participants without family history of alcohol dependence. The investigators also explore the relation between familial density of alcoholism and cognitive performance, particularly mental flexibility and inhibition. Genetic analysis will also be conducted to investigate the relationship between cognitive performance and genetic patterns (single nucleotide polymorphisms).


Recruitment information / eligibility

Status Terminated
Enrollment 261
Est. completion date July 2009
Est. primary completion date March 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

Alcohol-dependent patients :

- Males or females, aged 18-65 years, with a diagnosis of alcohol dependence, according to the DSM-IV criteria

- Patients withdrawn from alcohol at least 2 weeks

- Native French speaker, able to read French and complete study evaluations

- Caucasian

- Able to provide informed written and verbal consent

First-degree relatives of alcohol-dependent probands :

- Males or females, aged 18-65 years

- Caucasian

- Native French speaker, able to read French and complete study evaluations

- Able to provide informed written and verbal consent

Healthy Controls :

- Males or females, aged 18-65 years

- Caucasian

- Native French speaker, able to read French and complete study evaluations

- Able to provide informed written and verbal consent

Exclusion Criteria:

Alcohol-dependent patients

- DSM-IV substance use disorder other than alcohol

- Severe chronic psychiatric disorders including Bipolar disorder and schizophrenia

- Mood episode diagnostic according to the DSM-IV criteria in the last six months

- A significant general medical illness, including neurological disorders

- A sensorial impairment uncorrected (visual and/or hearing)

- Individuals who are not covered by national health insurance

First-degree relatives of alcohol-dependent probands :

- Past or recent alcohol and/or drug abuse or dependence

- Severe chronic psychiatric disorders including Bipolar disorder and schizophrenia

- Mood episode diagnostic according to the DSM-IV criteria in the last six months

- A significant general medical illness, including neurological disorders

- Handling of psychotropics substances

- A sensorial impairment uncorrected (visual and/or hearing)

- Individuals who are not covered by national health insurance

Healthy Controls :

- A personal or first-degree-relative history of alcohol dependence

- Past or recent alcohol and/or drug abuse or dependence

- Total abstinence from alcohol

- Severe chronic psychiatric disorders including Bipolar disorder and schizophrenia

- Mood episode diagnostic according to the DSM-IV criteria in the last six months

- A significant general medical illness, including neurological disorders

- Handling of psychotropics substances

- A sensorial impairment uncorrected (visual and/or hearing)

- Individuals who are not covered by national health insurance

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Behavioral:
Diagnostic Interview for Genetic Studies

Family Informant Schedule and Criteria

Temperament and Character Inventory

Barratt Impulsiveness Scale

Wisconsin Card Sorting Test

Genetic:
blood sample withdrawn


Locations

Country Name City State
France Chu de Reims Reims

Sponsors (1)

Lead Sponsor Collaborator
CHU de Reims

Country where clinical trial is conducted

France, 

References & Publications (4)

Benzerouk F, Gierski F, Gorwood P, Ramoz N, Stefaniak N, Hübsch B, Kaladjian A, Limosin F. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and its implication in executive functions in adult offspring of alcohol-dependent probands. Alcohol. 2013 Jun;47(4):271-4. doi: 10.1016/j.alcohol.2013.03.001. Epub 2013 Apr 10. — View Citation

Benzerouk F, Gierski F, Raucher-Chéné D, Ramoz N, Gorwood P, Kaladjian A, Limosin F. Association study between reward dependence and a functional BDNF polymorphism in adult women offspring of alcohol-dependent probands. Psychiatr Genet. 2015 Oct;25(5):208-11. doi: 10.1097/YPG.0000000000000099. — View Citation

Gierski F, Hubsch B, Stefaniak N, Benzerouk F, Cuervo-Lombard C, Bera-Potelle C, Cohen R, Kahn JP, Limosin F. Executive functions in adult offspring of alcohol-dependent probands: toward a cognitive endophenotype? Alcohol Clin Exp Res. 2013 Jan;37 Suppl 1:E356-63. doi: 10.1111/j.1530-0277.2012.01903.x. Epub 2012 Dec 14. — View Citation

Raucher-Chéné D, Gierski F, Hübsch B, Cuervo-Lombard CV, Bera-Potelle C, Cohen R, Kahn JP, Kaladjian A, Limosin F. Depression, anxiety and personality dimensions in female first-degree relatives of alcohol-dependent probands. Arch Womens Ment Health. 2012 Jun;15(3):229-32. doi: 10.1007/s00737-012-0271-5. Epub 2012 Mar 13. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary questionnaire comparison of questionnaires score for the 3 groups Day 0 No
Secondary genetic polymorphism Day 0 No
See also
  Status Clinical Trial Phase
Recruiting NCT05054738 - CRP and S&A for Inpatient Veterans N/A
Completed NCT02233738 - Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services N/A
Completed NCT05877807 - Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
Completed NCT00000437 - Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Phase 4
Completed NCT00536146 - The Stress-Hormone System in Alcohol-Dependent Subjects N/A
Terminated NCT00890149 - Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults Phase 2
Completed NCT02939352 - The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues Early Phase 1
Completed NCT02179749 - Mifepristone Treatment of Alcohol Use Disorder Phase 2
Completed NCT01553136 - Varenicline Treatment of Alcohol Dependence in Smokers Phase 2
Terminated NCT01408641 - Topiramate for Alcohol Use in Posttraumatic Stress Disorder N/A
Completed NCT01389297 - Overcoming Addictions: A Randomized Clinical Trial of a Web Application Based on SMART Recovery N/A
Completed NCT01113164 - Matching Genotypes and Serotonergic Medications for Alcoholism Phase 1
Completed NCT01760785 - Valproate for Mood Swings and Alcohol Use Following Head Injury N/A
Completed NCT00768508 - Combined Pharmacotherapies for Alcoholism Phase 3
Completed NCT00127231 - Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women N/A
Completed NCT00367575 - An Internet-based Intervention for Problem Drinking N/A
Completed NCT00223639 - New Medications to Treat Alcohol Dependence Phase 2
Completed NCT00583440 - 12-step Facilitation for the Dually Diagnosed Phase 1/Phase 2
Completed NCT00167687 - Prazosin Alcohol Dependence IVR Study Phase 4
Recruiting NCT00447785 - Endocrine Regulation of Energy and Fluid Supplies in Alcoholic Patients N/A